Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2004
04/15/2004WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
04/15/2004WO2004016607B1 Inhibition of phosphoinositide 3-kinase beta
04/15/2004WO2004005289A3 Efficient synthesis of pyropheophorbide a and its derivatives
04/15/2004WO2003101988A3 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
04/15/2004WO2003067286A3 Nanofilm and membrane compositions
04/15/2004WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
04/15/2004US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups
04/15/2004US20040073036 Substituted alkyl amido piperidines
04/15/2004US20040073033 Process for the preparation of phenylalanine enamide derivatives
04/15/2004US20040073026 Cyclic protein tyrosine kinase inhibitors
04/15/2004US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072861 Anxiolytic agents
04/15/2004US20040072859 Urea substituted imidazoquinoline ethers
04/15/2004US20040072858 Heterocyclic ether substituted imidazoquinolines
04/15/2004US20040072853 Therapeutic compounds
04/15/2004US20040072843 Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
04/15/2004US20040072837 Filtration; freeze drying; anticancer agents
04/15/2004US20040072836 Substituted aza-oxindole derivatives
04/15/2004US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease
04/15/2004US20040072831 Reverse-turn mimetics and method relating thereto
04/15/2004US20040072830 Squalene synthetase inhibitors; antilipemic agents; antiischemic agents; cardiovascular disorders; anticholesterol agents
04/15/2004US20040072817 Therapy for bacteria infections
04/15/2004US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
04/15/2004DE19948438B4 Bicyclische Imidazo-3-aminderivate Bicyclic imidazo-3-amine derivatives
04/15/2004DE19744257B4 Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen Beta-carbolines and their use for the treatment of malignant and other diseases based on pathological cell proliferations
04/15/2004DE10248067A1 New N-diaminophenylpropyl- or N-heteroarylpropyl-piperazine or piperidine derivatives, useful as dopaminergic and/or serotoninergic agents for e.g. treating Parkinson's disease or schizophrenia
04/15/2004CA2501502A1 Pyrazole derivatives
04/15/2004CA2500844A1 Bicyclic heteroaromatic compounds as kinase inhibitors
04/15/2004CA2500727A1 Vasculostatic agents and methods of use thereof
04/15/2004CA2500088A1 Morpholine-bridged indazole derivatives
04/14/2004EP1408040A1 Tricyclic fused heterocyclic compounds as CRFantagonists
04/14/2004EP1408034A1 Use of Quinoline derivatives as antibacterial agents
04/14/2004EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives
04/14/2004EP1406906A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
04/14/2004EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
04/14/2004EP1406900A1 Novel compounds, their preparation and use
04/14/2004EP1406897A2 Compounds
04/14/2004EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/14/2004EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/14/2004EP1406631A2 Dopamine receptor ligands and therapeutic methods based thereon
04/14/2004EP1406619A1 Antiviral and antimicrobial guanidine or biguanidine derivatives
04/14/2004EP1280804B1 A process for the preparation of anti-psychotic 3- 2- 4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2,-a]pyrimidin-4-one
04/14/2004EP1202994B1 New compounds
04/14/2004EP1171440B1 Substituted-3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
04/14/2004EP1073655B1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof
04/14/2004EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
04/14/2004EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
04/14/2004EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives
04/14/2004EP0921800B1 Substituted biphenyl isoxazole sulfonamides
04/14/2004EP0912565B1 Process for preparing imidazoquinolinamines
04/14/2004CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives
04/14/2004CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
04/14/2004CN1489458A Inhibitors against the production and releaseof inflammator cytokines
04/14/2004CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof
04/13/2004US6720422 Amide substituted imidazopyridines
04/13/2004US6720341 Preventives/remedies for kidney diseases
04/13/2004US6720339 Such as n-phenyl-4-oxo-6,6-dimethyl-4,5,6,7-tetrahydro-1h-indole-3-carboxamide; for diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and for memory enhancement
04/13/2004US6720334 Immune response modifiers; cytokine biosynthesis; viral and neoplastic diseases; 1-(4-(4-amino-6,7-dimethyl-1h-imidazo (4,5-c)pyridin-1-yl)butyl)-3-phenylurea.
04/13/2004US6720333 Amide substituted imidazopyridines
04/13/2004US6720332 Oxindole derivatives
04/13/2004US6720331 Having anti-mitotic activity for therapy of cancer
04/13/2004US6720324 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
04/13/2004US6720317 Inhibitors of factor Xa
04/13/2004US6720188 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample
04/13/2004US6719339 Vehicle protection assembly
04/08/2004WO2004029055A1 Fused azole-pyrimidine derivatives
04/08/2004WO2004029053A1 Novel 1,4-diazabicycloalkane derivatives, their preparation and use
04/08/2004WO2004029052A1 Process for preparing haloalkyl pyrimidines
04/08/2004WO2004029051A1 Pyrazole amides for treating hiv infections
04/08/2004WO2004029040A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
04/08/2004WO2004028540A1 Anti-neurodegenerative agents
04/08/2004WO2004028539A2 1h-imidazo dimers
04/08/2004WO2004028459A2 Piperidine derivatives
04/08/2004WO2004016741A3 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
04/08/2004WO2004016604A3 Azabicyclic compounds are central nervous system active agents
04/08/2004WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses
04/08/2004WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
04/08/2004WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
04/08/2004WO2003086314A3 Tyrosine kinase inhibitors
04/08/2004WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects
04/08/2004WO2003057667B1 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications
04/08/2004US20040068115 Charge transport compositions and electronic devices made with such compositions
04/08/2004US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration
04/08/2004US20040067998 Oral administering
04/08/2004US20040067997 Respiratory syncytial virus
04/08/2004US20040067994 Grampositive, gramnegative bacteria therapy
04/08/2004US20040067976 Compounds useful for treating Hepatitis C virus
04/08/2004US20040067975 Amido ether substituted imidazoquinolines
04/08/2004US20040067974 Alzheimer's disease; Down's syndrome; synergistic mixture containing galanthamine
04/08/2004US20040067964 Antiinflammatory agents
04/08/2004US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders
04/08/2004US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction
04/08/2004US20040067924 Actinium-225 complexes and conjugates for targeted radiotherapy
04/08/2004US20040067852 For plants; fungicides
04/08/2004US20040067531 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
04/08/2004US20040067256 Novel modified release formulation
04/08/2004US20040067252 Novel modified release formulation
04/08/2004US20040066135 Electronic devices made with electron transport and/or anti-quenching layers